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Sir,
Intravascular papillary endothelial hyperplasia (IPEH) 
was first described by Masson (1) as a neoplastic lesion 
“vegetant intravascular haemangioendothelioma”. In 
1976, Clearkin & Enzinger (2) proposed the term IPEH, 
which is currently known as a non-neoplastic reactive en-
dothelial proliferation. The lesions are frequently situated 
in the deep dermis and subcutis of the fingers, head and 
neck. In subcutaneous localizations the lesion may appear 
clinically as a small, firm, superficial nodule imparting a 
red-to-blue discoloration of the overlying skin. We de-
scribe here a rare case of IPEH on the lower leg, which 
resembled malignant melanoma in appearance. 
CASE REPORT
A 62-year-old woman presented with a 1-month history of abruptly 
grown skin lesion on her lower leg. The patient did not recall any 
preceding trauma. Physical examination revealed a black-coloured, 
dome-shaped nodule, 8 mm in diameter (Fig. 1). She had been 
diagnosed with end-stage renal disease 20 years previously, and 
since then she had received continuous ambulatory peritoneal 
dialysis (CAPD). Histopathological examination revealed a mass 
of vascular channels with prominent intraluminal papillary pro-
jections in the dermis (Fig. 2a). The papillary projections were 
composed of a single layer of plump endothelial cells around a 
core of fibrous connective tissue (Fig. 2b). Characteristically, the 
papillary structures were either attached to the internal surface of 
the vessel wall or apparently lying in the lumen. The endothelial 
cells showed no significant nuclear atypia or mitotic figures, no 
necrosis or invasion into surrounding tissues. Thrombus formation 
and excessive fibrin deposition were not observed. The pathologi-
cal diagnosis was established as IPEH. 
DISCUSSION
IPEH is characterized by the development of endothe-
lial papillary projection into the vascular lumen. IPEH 
arises most often in middle-aged adults, with a slight 
predilection for females. Although it may occur in any 
location in the body, only a few cases of IPEH on lower 
leg have been reported (2–4). Three different types of 
IPEH have been recognized: (i) a primary (pure) form, 
in which changes are observed in a dilated vessel or 
organizing thrombi; (ii) a secondary (mixed) form with 
incidental microscopic findings or pre-existing vascular 
tumour; (iii) an uncommon type that is extravascular 
in origin (3). The pure form of IPEH is reported to 
comprise approximately 33% of all IPEHs (3). Our case 
was also a pure form of IPEH that occurred in a dilated 
vessel, but organizing thrombi were not observed.
The exact pathogenesis of IPEH remains unknown, 
but an unusual form of thrombus organization following 
a trauma is considered to play a role (3). Levere et al. 
(5) demonstrated elevated levels of basic fibroblast 
growth factor (bFGF) in cases of IPEH compared with 
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Fig. 2. (a) The mass of vascular channels with prominent intraluminal papillary 
projections in the dermis. (b) The papillary projections were composed of a 
single layer of plump endothelial cells around a core of fibrous connective 
tissue (haematoxylin and eosin staining: (a) ×100; (b) ×200). 
Fig. 1. A 62-year-old woman presented with a black, dome-shaped, firm 
nodule on her lower leg. 
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non-IPEH organizing thrombi. They proposed that the 
release of bFGF from macrophages recruited to the 
lesion is proposed to trigger the proliferation of endothe-
lial cells, which in turn release more bFGF, leading to 
a vicious cycle (5). Hormonal influence also has been 
suggested due to its slight female preponderance (6). 
The differential diagnosis of IPEH includes other 
benign and malignant vascular proliferative disorders, 
such as pyogenic granuloma, Kaposi’s sarcoma, haem-
angioma, and angiosarcoma (7). However, the main 
concern in forming clinicopathological diagnosis is 
differentiation of IPEH from angiosarcoma. A helpful 
differential point is its intravascular location, since 
angiosarcomas are almost never confined to a vascular 
lumen. It also differs from angiosarcoma in that the 
endothelial cells lack necrosis, marked pleomorphism, 
significant mitotic activity, and solid sheet formation 
(8). Clinically, it is almost impossible to make an exact 
diagnosis of IPEH just by inspecting the lesion. The 
usual clinical appearance of IPEH is an elevated, firm 
and sometimes tender nodule that imparts a slight purp-
lish red colour to overlying skin or mucous membrane. 
We report here an IPEH on lower leg of female with 
unusual clinical appearance. As far as we know, there 
have been no reports of IPEH presenting as a strongly-
black coloured firm nodule, which is very similar to 
malignant melanoma. However, malignant melanoma 
can easily be differentiated by pathological examination. 
It is interesting that IPEH, which is a completely benign 
condition, may resemble two of the most noto riously 
malignant skin cancers, malignant melanoma and 
angiosarcoma, in clinical appearance and histological 
features, respectively.
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